Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.59
16.58
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Zhejiang Ausun Pharmaceutical Co Ltd
Zhejiang Ausun Pharmaceutical Co Ltd
Accrued Liabilities
Zhejiang Ausun Pharmaceutical Co Ltd
Accrued Liabilities Peer Comparison
600436
600276
000538
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229
|
Accrued Liabilities
¥26.2m
|
CAGR 3-Years
18%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accrued Liabilities
¥2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Accrued Liabilities
¥620.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
39%
|
CAGR 10-Years
35%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accrued Liabilities
¥128.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accrued Liabilities
¥1.5B
|
CAGR 3-Years
48%
|
CAGR 5-Years
46%
|
CAGR 10-Years
59%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Accrued Liabilities
¥146m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Zhejiang Ausun Pharmaceutical Co Ltd's Accrued Liabilities?
Accrued Liabilities
26.2m
CNY
Based on the financial report for Jun 30, 2024, Zhejiang Ausun Pharmaceutical Co Ltd's Accrued Liabilities amounts to 26.2m CNY.
What is Zhejiang Ausun Pharmaceutical Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
25%
Over the last year, the Accrued Liabilities growth was -39%. The average annual Accrued Liabilities growth rates for Zhejiang Ausun Pharmaceutical Co Ltd have been 18% over the past three years , 25% over the past five years .
You don't have any saved screeners yet
